Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie’s disease: a retrospective comparative analysis-Reference-Cited by-同舟云学术

Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie’s disease: a retrospective comparative analysis

Published:2022-12-13 Issue: Volume: Page:
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Spirito Lorenzo,Manfredi Celeste^ORCID,La Rocca Roberto,Napolitano Luigi,Di Girolamo Antonio,Capece Marco^ORCID,Trama Francesco,Sciorio Carmine,Sokolakis Ioannis^ORCID,Creta Massimiliano^ORCID,Arcaniolo Davide^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://www.nature.com/articles/s41443-022-00651-8.pdf

Reference33 articles.

1. Miner MM, Seftel AD. Peyronie’s disease: epidemiology, diagnosis, and management. Curr Med Res Opin. 2014;30:113–20.

2. Piraino J, Chaudhary H, Ames K, Okoye F 3rd, Sterling M, Clavell-Hernandez J, et al. A consistent lack of consistency in defining the acute and chronic phases of Peyronie’s disease: a review of the contemporary literature. Sex Med Rev. 2022;10:698–713.

3. Punjani N, Nascimento B, Salter C, Miranda E, Terrier J, Taniguchi H, et al. Predictors of Depression in Men With Peyronie’s Disease Seeking Evaluation. J Sex Med. 2021;18:783–8.

4. Mulhall JP, Schiff J, Guhring P. An Analysis of the Natural History of Peyronie’s Disease. J Urol. 2006;175:2115–8.

5. Weidner W, Schroeder-Printzen I, Weiske WH, Vosshenrich R. Sexual Dysfunction in Peyronie’s Disease: An Analysis of 222 Patients Without Previous Local Plaque Therapy. J Urol. 1997;157:325–8.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Current International Guidelines on Premature Ejaculation: 2024 Update;Diagnostics;2024-08-21

2. Acute Phase Peyronie’s Disease: Where Do We Stand?;Cureus;2024-08-17

3. Prise en charge de la maladie de Lapeyronie au stade précoce, une revue narrative de la littérature;Progrès en Urologie - FMC;2024-06

4. Response to: “Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s disease: a retrospective cohort study”;International Journal of Impotence Research;2024-03-22

5. Unveiling treatment horizons and contemporary perspectives in Peyronie’s disease – take home messages from Laurance A. Levine special issue;International Journal of Impotence Research;2024-02-19